Spirepoint Private Client »

Vaneck Vectors Pharmaceutical etf shares owned by Spirepoint Private Client

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Spirepoint Private Client from 13F filings

Historical chart of Spirepoint Private Client investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Spirepoint Private Client consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Spirepoint Private Client

Quarter filed Position value Share count Share price at filing
2024-03-31 $995k 11k 90.70

More positions owned by Spirepoint Private Client

United Parcel Service CL B (UPS)
Microsoft Corporation (MSFT)
Apple (AAPL)
Clean Harbors (CLH)
Rivian Automotive Com Cl A (RIVN)
Johnson & Johnson (JNJ)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Procter & Gamble Company (PG)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Select Sector Spdr Tr Technology (XLK)
Nextera Energy (NEE)
Eli Lilly & Co. (LLY)
Alps Etf Tr Alerian Mlp (AMLP)

View all positions for Spirepoint Private Client

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Northwestern Mutual Wealth Management Company
Miller Investment Management
Prime Capital Investment Advisors
Jpmorgan Chase & Co
Morgan Stanley
LPL Financial
Phoenix Holdings
Avestar Capital
J.Safra Asset Management
Susquehanna International
Citadel Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf